Patient-derived monoclonal antibodies to sars-cov-2 nucleocapsid protein n-terminal and c-terminal domains cross-react with their counterparts of sars-cov, but not other human betacoronaviruses

HIGHLIGHTS

• who: Yingfen Wen and colleagues from the United States Emory University, United States have published the article: Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses, in the Journal: (JOURNAL)

SUMMARY

The authors also tested 52 plasma samples collected from convalescent COVID-19 patients for Abs against the N proteins of human b-CoVs and found that 78.8% of plasma samples showed detectable Abs against the N proteins of SARS-CoV-2 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.